We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Maelor | LSE:MLR | London | Ordinary Share | GB00B2QBY649 | ORD 70P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 100.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/10/2007 14:58 | think i have................ | fo77y | |
02/10/2007 10:14 | I wonder how may people have died waiting for MLR to come good? | jim_bently davis | |
23/9/2007 10:20 | AMS up 30% since IC mention with MLR at the time which has been a bit worse for wear. Hopefully MLR will catch up. Beleive at the time of the write up MLR was 15p and AMS was 20p MLR now 12p and AMS now 26p. | guru11 | |
21/9/2007 13:36 | Picked up some more today as I don't think it's going any lower! | gogoneko | |
19/9/2007 15:37 | It'll be interesting to see if the today's buys are the directors. It happened around the same time last year corresponding to the imminent close period. | gogoneko | |
19/9/2007 11:55 | jim, I read that post by harrylyme but certainly didn't see it as a reason not to invest. Your emotive reaction to it seems fickle to me. The 'sizzle' is for short-term trading but the 'sausage' is more relevant to those taking an investment approach. Both can make (and lose) you money but I see MLR as an investment over a 1-2 year view cause I think they now have substance as a GARP share (rather than the previous sizzle over micelle propofol that came to nothing). BTW, what's your interest in this company? | crazycoops | |
19/9/2007 06:08 | Good post But I still have Jim filtered and have not read what he wrote. | darias | |
18/9/2007 22:38 | crazycoops, I just read what jim writes (because I have to remove the filter) and I agree with you that it's no surprise to see the share within the trading range. The only reason I see that it was unable to break the range and head higher into speculative territory (rather than on valuation) was because there was such heavy selling by privileged investors at and above 15p. I think a lot of investors are selling at the disappointment that the shares haven't rocketed (such is the fickle nature of small private investors) or, most likely, are going to try to get in at a lower price. I've done a bit of the latter but even so am content to be holding the majority long-term because the company, apart from setting a questionable placing price, has done nothing wrong. All these jibes at the management and the company are seriously misplaced considering the recent acquistion and strategic decisions and subsequent metamorphosis into a very profitable company with plenty of cash. Furthermore, from recent comments, everything is still going to plan - so what unfounded griping by some commentators! Sure if the results indicate problems then we can all jump on the critical bandwagon but it's too early at this point. If these tempramental investors don't do their sums and expect a new deal every month and a ridiculous valuation they probably spend their time chasing one share after another with their hot money and blaming management rather than themselves when the choice backfires. Can't imagine we'll get a pre-close update following so closely to the previous AGM update, unless the stock does drop out of the range. I'll be more than happy to pick more up for 11p again if it drops that far - particularly with results so close. | gogoneko | |
18/9/2007 15:09 | YOU BLIND CRAZYCOPS its here taken for the MLR thread om MW WITH ALL DUE ACKNOWLEDGEMENT---YO Recommendations: 8 I took the trouble to go to London, despite tales of Tube woes, etc. to attend the Maelor AGM. Arrived ten minutes early and the room was empty! AT the appointed time it had filled a tiny bit - mostly Execs and their hangers-on....so if anyone (here) was present I didn't spot you - or I'd have said "Hello". The formalities over there were no questions - indeed there were no other Retail Investors there, although I did manage to get some information informally - the Placing was effectivly a reverse - - - yet I consider the Placing to be a huge dilution - indeed the Board may be pleased the share price has risen above the 10p Placing - but for retail investors the dilution by extra shares, it should be! Our prospects for a dividend are half what they were. There was no presentation, so I was glad a friend who planned to attend, couldn't make it - it would have been an episode that wouild take a long time to forget. (It is my belief that at every Public presence, the company should be making the case for investment, showing how the business is going and (hoping potential investors will buy-in).....to forget that aspect of a public platform is a serious error and I shan't be investing more in this outfit. The real question is - with this new business:- is the new company worth more than the two businesses on their own? IMHO [MLR] has been in free-fall for a long time, so I guess the market is waiting, before it heads one way, or the other,. This stock doesn't appear to be discussed (here), so I guess that tells all long-term investors something about the business as a whole. "Lack of sizzle" sums it up. The Resolutions were voted through and the Proxy votes were just over 20m each, "for"......... Against was barely 1,000's. Quite a contrast to OXB's AGM (in the same building, I think) where Prof Kingsman takes the trouble to explain their technologies, the progress to Market and their Cash and Deals - nothing that isn't already Public; but it's good to have it in a concise manner, so one can get a view on "the buzz" - from the Top, as it were. | jim_bently davis | |
18/9/2007 11:33 | jim, I am a subscriber to MW and cannot see anything there that supports your comment above. As I have said previously on this board, there are two points at which we are likely to see any sort of re-rating with MLR - either at the end of this month with a pre-close trading update or 6 weeks or so later with the actual interim results (notwithstanding unexpected newsflow). In the meantime, we are towards the bottom end of a clearly established trading range. If results are good (although I am not sure what "the board's expectations" are) we will see a re-rating and a new trading range established. FWIW I rate MLR as a GARP share (Growth At a Reasonable Price). All IMHO. | crazycoops | |
15/9/2007 12:58 | I told you clowns month and month ago this was dead in the water, for those of you who can read the Mike Walters site, MLR is being run for the benefit of its over paid board of directors and insitutional club memebers you smaller guys dont have a hope in hell with this one Sell it. | jim_bently davis | |
10/9/2007 09:38 | Well posted and spot on, what we need now is a good news flow from the interim accounts to move us on. | piruxi | |
10/9/2007 09:29 | gogoneko / hard work I think we are all playing around with various assumptions to gauge profitability. Cannot agree more that we need the interims to gauge true performance. I would add the following points though, that are not interims related 1) Close on 50% of shares (MLR website) are owned by institutions (each having 3% or more of MLR)& none have sold during the recent market turmoils (else an RNS would have been released). So its not only us who are bullish on MLR. 2) I do not believe terms such as "aggressive growth plans" (from agm) are issued lightly by this management. I do believe they are setting about moving MLR to another level. 3) I believe a re-rating of the shares is more a matter of when & not if. This will happen once a clear track record has been established. Now if that means after the next interims or after a couple more result announcements - I do not know - I have never been any good at timing. In the meantime, I am happen to add to my MLR position at these levels while I can. | asp5 | |
09/9/2007 06:32 | Gogoneko - £7.9m @59% margin = £4.6m less £2m costs = £2.6m. The £1m you deduct from this for the Acorus payment is a cash payment, not a P & L payment is it not? I recall from the fundraising for the Acorus deal that their GM was about £2m and, due to synergies, (Maelor had all the infastrucutre in place)most of this would flow to the bottom line. I agree - we need the iterims... | hard work | |
09/9/2007 01:14 | great posting well done. | piruxi | |
08/9/2007 18:37 | So as not to be accused of wearing rose-tinted glasses here's a bit of slightly out-of-date but nonetheless relevant information regarding Ashton Pharma, the company Acorus entered into a 3-yr contract with to distribute mysoline: Before holders panic (which might not be so easy considering the dow's retreat yesterday) the article is two months old (so well before last week's AGM update saying that everything is fine) and that the legal fight is between Ashton's parent company, Inyx, and Westernbank. Also MLR don't use Ashton for UK and Ireland. | gogoneko | |
07/9/2007 16:20 | The man BMW is a luney I have only ever posted here, and that was about three since. I only post good stuff always positive and up beat read my posts. | piruxi | |
07/9/2007 15:57 | Sorry guys but this moron has wrecked many threads on ADVFN..iii and am in the past...at the moment he is the top idiot on the LIAR BB. Therefore wherever I suspect him/her is posting and steps out of line I will expose the prat. If I upset posters in the process...I apologise. | 525bmw |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions